Arcturus Therapeutics Holdings Inc.ARCTNASDAQ
Loading
Cost of Revenue Over TimeContracting
Percentile Rank86
5Y CAGR-40.9%
Studio
Year-over-Year Change

Direct costs attributable to producing goods sold

5Y CAGR
-40.9%/yr
Long-term compound
Percentile
P86
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
1 yr
Consecutive growthContracting
PeriodValueYoY Change
TTM$4.02M-
2024$0.00-
2023$0.00-
2022$0.00-
2021$0.00-100.0%
2020$55.95M-
2019$0.00-100.0%
2018$16.98M+4042.0%
2017$410000.00+39.5%
2016$294000.00-